The Glucosides from Swertia mussotii Franch

Swertia mussotii Franch. is a herb used for treatment of liver disease in Qinghai-Tibcran Plateau folk. Further investigation on chemical constituents in aqueous extract of Swertia mussotii Franch. has been reported here. Seven compounds (Ⅰ, Ⅲ–Ⅷ) were achieved except mangiferin (Ⅱ) isolated previously by a chromatograph. They belong in secoiridoids, flavonoids and xanthonoids, respectively. The structures of known compounds were identified as amarogentin(Ⅲ), swertisin(Ⅷ), 8-O-β-D-glucopyranosyl-1, 3, 5-trihydroxyxanthone(Ⅶ) and 8-O-β-D-glucopyranosyl-(1-6)-β-D-glucopyranosyl)-I, 7-dihydroxy-3-methoxyxanthone (Ⅵ). The structures of other three new compounds have been elucidated as 7-O-β-D-xylopy-ranosyl-1, 8-dihydroxy-3-methoxyxanthone (Ⅳ), 7-O-[α-L-rhamnopyranosyl- (1-2)-β-D-xylopyranosyl]-l,8-dihydroxy-3-methoxyxanthone(Ⅰ)and 3-O-β-D-glucopyranosy 1,8-dihydroxy-5-methoxyxanthone (Ⅴ), by means of the chemical and spectral methods. Mangiferin, amarogentin and 7-0- [α-L-rhamnopyranosyl-(1-2)-β-D-xylopyranosyl]-l,8-dihydroxy-3-methoxyxanthone are the principal glucosides in this plant.     

Study on Chemical Constituents of Gentianopsis barbata var. Stennocalyx H. W. Li ex T.N. Ho

Nine compounds were isolated from Gentianopsis barbata var. stennocalyx H. W. Li ex. T.N.Ho. Their structures are identified as 1-hydroxy4, 7, 8-trimethoxyxanthone (Ⅰ), 1, 7-dihydroxy-3, 8-dimethoxyxanthone (Ⅱ), 1, 7, 8-trihydroxy-3-methoxyxanthone (Ⅲ), 1-O-(β-D- xylopyranosyl-(1→6)-β-D-glucopyranosyl)-3, 7, 8-trimethoxyxanthone (Ⅳ), 1-O-(β-D-xylopy- ranosyl- (1→6)-β-D-glucopyranosyl)-7-hydroxy-3, 8-dimethoxyxanthone (Ⅴ), 1-O-(β-D-xylo- pyranosyl-(1→6)-β-D-glucopyranosyl)-7, 8-dihydroxy-3-methoxyxanthone (Ⅵ), luteolin-7-O- β-D-glucoside (Ⅶ), oleanolic acid (Ⅷ) and ursolic acid (Ⅸ) by means of chemical methods and UV, IR and NMR determinations respectively.     

羽叶鬼灯檠中的单萜二糖苷

从羽叶鬼灯檠 (RodgersiapinnataFranch .)的根茎中分离得到 6个单萜二糖苷 ,它们的结构通过波谱方法分别鉴定为 :(E ) 3,7 dimethyl 1 O [α L rhamnopyranosyl (1→ 6 ) β D glu copyranosyl] oct 2 en 7 ol (1) ,(E ) 3,7 dimethyl 1 O [α L arabinofuranosyl (1→ 6 ) β D glucopy ranosyl] oct 2 en 7 ol (2 ) ,geranyl 1 O α L arabinofuranosyl (1→ 6 ) β D glucopyranoside (3) ,gera nyl 1 O α L rhamnopyranosyl (1→ 6 ) β D glucopyranoside (4 ) ,geranyl 1 O β D xylopyranosyl (1→6 ) β D glucopyranoside (5 ) ,geranyl 1 O α L arabinopyranosyl (1→ 6 ) β D glucopyranoside (6 )。其中化合物 1为新化合物 ,单萜二糖苷类化合物系首次在该属中发现。     

Acylated protopanaxadiol-type ginsenosides from the root of Panax ginseng

Six new protopanaxadiol-type ginsenosides, named ginsenosides Ra(4) -Ra(9) (1-6, resp.), along with 14 known dammarane-type triterpene saponins, were isolated from the root of Panax ginseng, one of the most important Chinese medicinal herbs. The structures of the new compounds were determined by spectroscopic methods, including 1D- and 2D-NMR, HR-MS, and chemical transformation as (20S)- 3-O-{β-D-6-O-[(E)-but-2-enoyl]glucopyranosyl-(1→2)-β-D-glucopyranosyl}-20-O-[β-D-xylopyranosyl-(1→4)-α-L-arabinopyranosyl-(1→6)-β-D-glucopyranosyl]protopanaxadiol (1), (20S)-3-O-[β-D-6-O-acetylglucopyranosyl-(1→2)-β-D-glucopyranosyl]-20-O-[β-D-xylopyranosyl-(1→4)-α-L-arabinopyranosyl-(1→6)-β-D-glucopyranosyl]protopanaxadiol (2), (20S)-3-O-{β-D-6-O-[(E)-but-2-enoyl]glucopyranosyl-(1→2)-β-D-glucopyranosyl}-20-O-[β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl]protopanaxadiol (3), (20S)-3-O-{β-D-6-O-[(E)-but-2-enoyl]glucopyranosyl-(1→2)-β-D-glucopyranosyl}-20-O-[α-L-arabinopyranosyl-(1→6)-β-D-glucopyranosyl]protopanaxadiol (4), (20S)-3-O-{β-D-4-O-[(E)-but-2-enoyl]glucopyranosyl-(1→2)-β-D-glucopyranosyl}-20-O-[α-L-arabinofuranosyl-(1→6)-β-D-glucopyranosyl]protopanaxadiol (5), (20S)-3-O-{β-D-6-O-[(E)-but-2-enoyl]glucopyranosyl-(1→2)-β-D-glucopyranosyl}-20-O-[α-L-arabinofuranosyl-(1→6)-β-D-glucopyranosyl]protopanaxadiol (6). The sugar moiety at C(3) of the aglycone of each new ginsenoside is butenoylated or acetylated.     

Three New Glycosides from Halenia clliptica

Three new glycosides have been obtained from the herb Halenia elliptica D. Don (Genti- anaceae) which is used for treatment of liver diseases in Qinghai-Tibetan folk. Their structu- res have been identified as 1-O-[β-D-xylopyranosyl-(1→6)-β-D-glucopyranosyl]-2,3,5,7-terameth-oxyxanthone(Ⅰ) or as l-O-primeverosyl-2,3,5,7-tetramethoxyxanthone),1-O-[β-D-xylopyranosyl-(1-6)-β-D-glucopyranosyl]-2,3,5-trimethoxyxanthone (Ⅱ, or as 1-O-primeverosyl-2,3,5-trimeth- oxyxanthone), and 1-O-[β-D-xylopyranosyl-(1-6)-β-D-glucopyranosyl]-2,3,4,5-tetramethoxyxan- thone (Ⅲ, or as 1-O-primeverosyl-2,3,4,5-tetramethoxyxanthone) respectively, by means of che- mical and spectral methods. Ⅰ and Ⅱ are another two new antihepatitisic constituents of this species, and their biological activity of antihepatitis has been displayed by the pharmacological research. They were named haleniaside (Ⅰ) and demethoxyhaleniaside (Ⅱ).     

Triterpene saponins from Cyclamen hederifolium

Five triterpene saponins never reported before, hederifoliosides A-E, and four known triterpene saponins were isolated from the tubers of Cyclamen hederifolium. The structures of hederifoliosides A-E were determined as 3β,16α-dihydroxy-13β,28-epoxyolean-30-oic acid 3-O-{[β-D-glucopyranosyl-(1 → 2)-O]-β-D-xylopyranosyl-(1 → 2)-O-β-D-glucopyranosyl-(1 → 4)-O-α-L-arabinopyranoside}, 3β,16α-dihydroxy-13β,28-epoxyolean-30-oic acid 3-O-{[β-D-glucopyranosyl-(1 → 2)-O]-β-D-xylopyranosyl-(1 → 2)-O-[β-D-glucopyranosyl-(1 → 3)]-O-β-D-glucopyranosyl-(1 → 4)-O-α-L-arabinopyranoside}, 3β,16α-dihydroxy-13β,28-epoxyolean-30-al 3-O-{[β-D-glucopyranosyl-(1 → 2)-O]-β-D-xylopyranosyl-(1 → 2)-O-[β-D-glucopyranosyl-(1 → 3)]-O-[β-D-glucopyranosyl-(1 → 6)]-O-β-D-glucopyranosyl-(1 → 4)-O-α-L-arabinopyranoside}, 30-O-β-D-glucopyranosyl-(1 → 2)-O-β-D-glucopyranosyl-3β,16α,30-trihydroxyolean-12-en-28-al 3-O-{[β-D-glucopyranosyl-(1 → 2)-O]-β-D-xylopyranosyl-(1 → 2)-O-β-D-glucopyranosyl-(1 → 4)-O-α-L-arabinopyranoside}, 30-O-β-D-glucopyranosyl-(1 → 2)-O-β-D-glucopyranosyl-3β,16α,28,30-tetrahydroxyolean-12-en 3-O-{[β-D-glucopyranosyl-(1 → 2)-O]-β-D-xylopyranosyl-(1 → 2)-O-[β-D-glucopyranosyl-(1 → 3)]-O-β-D-glucopyranosyl-(1 → 4)-O-α-L-arabinopyranoside}, by a combination of one- and two-dimensional NMR techniques, and mass spectrometry. The cytotoxic activity of the isolated compounds was evaluated against a small panel of cancer cell lines including Hela, H-446, HT-29, and U937. None of the tested compounds, in a range of concentrations between 1 and 50 μM, caused a significant reduction of the cell number.     

Xanthone O-glycosides from Polygala tenuifolia

Four xanthone O-glycosides, polygalaxanthones IV-VII were isolated from the roots of Polygala tenuifolia Willd., together with eight known compounds. The structures of the four xanthone O-glycosides were established as 6-O-[alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranosyl]-1-hydroxy-3,7-dimethoxyxanthone (polygalaxanthone IV), 6-O-[alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranosyl]-1,3-dihydroxy-7-methoxyxanthone (polygalaxanthone V), 6-O-(beta-D-glucopyranosyl)-1,2,3,7-tetramethoxyxanthone (polygalaxanthone VI), and 3-O-[alpha-D-rhamnopyranosyl-(1-->2)-beta-D-glucopyranosyl]-1,6-dihydroxy-2,7-dimethoxyxanthone (polygalaxanthone VII), respectively, on the basis of analysis of spectroscopic evidence.     

The Xanthones of Swertia erythtrosticta Maxim

Swertia erythrosticta Maxim. (Gentianaceae) is a herb used for curing some diseases in Tibetan traditional medicine system. Eight xanthones were isolated from this species. Their structures were identified as 1,8-dihydroxy-3,7-dimethoxyxanthone(Ⅰ), 1,5,8-trihydroxy-3-methoxyxanthone (Ⅱ), 1,3,8-trihydroxy-5-methoxyxanthone (Ⅲ), 1,7,8-trihydroxy-3-methoxyxanthone (Ⅳ), 1,3,5,8-tetrahydroxyxanthone (Ⅴ), 1,3,7,8-tetrahydroxyxanthone(Ⅵ), as well as 8-O-β-D-glucopyranosyl-1, 5-dihydroxy-3 -metho xy xanthone(Ⅶ), 8-O-β-D-gl ucopyr anosyl- 1,3,5- trihydroxyxanthone(Ⅷ) by means of chemical methodes and spectral analyses.     

On the Xanthone Glycosides and Flavonoid Glucoside from Swertia franchetiana H. Smith

Three xanthone glycosides, a flavonoid glucoside and a triterpen acid have been isolated from Swertia franchetiana H. Smith (Gentianaceae). One of them is a new xanthone glyco- side and its stucture is established as 1-O-[β-D-xylopyranosyl-(1-6)-β-D-glucopyranosyl] 3, 5-dimethoxyxanthone (Ⅺ), Others are identified as swertianolin, swertisin, mangiferin and oleanolic acid by chemical and spectral means, respectively.     

无柄新乌檀中的配糖体

从无柄新乌檀乙醇浸膏的正丁醇部位分离得到7个已知配糖体化合物,经波谱分析为：喹诺酸-3-O-β-D-葡萄吡喃糖基(28→1)-β-D-葡萄吡喃糖酯(1),齐墩果酸-(28→1)-β-D-葡萄吡喃糖酯(2),熊果酸-(28→1)-β-D-葡萄吡喃糖酯(3),喹诺酸-3-O-β-D-葡萄吡喃糖基-(1→3)-6-去氧-β-葡萄吡喃糖苷(4),齐墩果酸-3-O-β-D-吡喃木糖基-(1→2)-β-D-葡萄吡喃糖基-28-O-β-D-葡萄吡喃糖酯(5),番木鳖甙(6),7-甲氧基-龙胆苦甙(7)。这些化合物均为首次从该属中分离得到。     

Study on the Chemical Constituents of Comastoma pulmonarium (Turcz.) Toyohuni

Eight compounds were isolated from Comastoma pulmonarium (Gentianaceae). Theirstructures are identified as1,8-dihydroxy-3,5-dimethoxyxanthone(Ⅰ),1,8-dihydroxy-3,7-dimetho-xyxanthone(Ⅱ), 1-hydroxy-3,7,8-trimethoxyxanthone(Ⅲ),8-hydroxy-l,3,5-trimethoxyxanthone(Ⅳ), 1,3,8-trihydroxy-7-methoxyxanthone(Ⅴ), 1-O-β-D-glucopyranosyl-3,8-dihydroxy-7-methxy-xanthone(Ⅵ), oleanolic acid(Ⅶ) and swertisin(Ⅷ) by means of chemical methods andUV, IR, NMR and MS respectively. The compound Ⅵ is a new natural product. It wasnamed as comastomaside.     

青蕨植物化学成分的研究

从青蕨根部的乙酸乙酯提取物中分离得到4个化合物。通过化学及波谱分析鉴定其结构为：saucerneol D(1),dehydrogoniothalamin(2),1-acetoxyl-2-piperonyl-6-[6-methoxyl-piperonyl]3,7-dioxabicyclo-[3,3,0]-octane(3) and 5,5′-dihydroxy-3-methoxy-6,8,3″,3″-tetramethylpyran-(3′,4′)flavone-7-O-[β—D—apiofuranosyl-(1→6)]-β-D-glucopyranoside(4)。其中化合物(4)为新化合物,化合物(1)为首次从该属植物中分离得到。     

Xanthones from Hypericum chinense

Six xanthones, 1,3,7-trihydroxy-2-(2-hydroxy-3-methyl-3-butenyl)-xanthone (1), 1,7-dihydroxy-2,3-[2'-(1-hydroxy-1-methylethyl)-dihydrofurano]-xanthone (2), 1,3,7-trihydroxy-5-methoxyxanthone (3), 1,7-dihydroxy-5,6-dimethoxyxanthone (4), 4,5-dihydroxy-2,3-dimethoxyxanthone (5), 1,3-dihydroxy-2,4-dimethoxyxanthone (6) and 21 known xanthones were isolated from the leaves and stems of Hypericum chinense. Their structures were established based on spectroscopic studies.     

Isolation and Identification of the Xanthone Constituents from Swertia mussotii Franch

Swertia mussotii Fraeh (Family Gentianaceae) is a herb used as medicine for liver diseases in Tibetan. Its principal antihepatitisic constituents, oleanolic acid and mangiferin, have been reported. The present paper reports eight xanthones obtained from this plant. Their structures have been identified as 1,8-dihydroxy-3,5-dimethoxyxanthone Ⅰ, 1-hydroxy-3,5-dimethoxyxanthone Ⅱ, 1-hydroxy-3,7,8-trimethoxyxanthone Ⅲ, 8-hydroxy- 1,3,5-trimethoxyxanthone Ⅳ, 1,8-dihydroxy-3,7-dimethoxyxanthone Ⅴ, 1,7,8-trihydroxy- 3-methoxyxanthone Ⅵ, 1,7-dihydroxy-3,4,8-trimethoxyxanthone Ⅶ, and 1,3,8-trihydro- xy-5-methoxyxanthone Ⅷ. Of them, 1,7-dihydroxy-3,4,8-trimethoxyxanthone is a new natural product.     

金铁锁的新三萜皂甙

从金铁锁（Psammosilene tunicoides W.C.Wu et C.Y.Wu)根部分离得到5个齐墩果烷型五环三萜皂苷,它们的结构通过波谱和化学方法分别鉴定为：3-O-β-D-galactopyranosyl-(1→2)-β-D-glucuronopyranosyl-gypsogenin(1),3-O-β-D-galactopyranosyl-(1→2)-[β-D-galactopyranosyl-(1→3)-β-D-glucuronopyranosyl-gypsogenin(2),3-O-β-D-galactopyranosyl-(1→2)-β-D-glucuronopyra-nosyl-gypsogenin-28-O-β-D-xylopyranosyl-(1→4)-[β-D-glucopyranosyl-(1→3)]-α-L-rhamnopyranosyl(1→2)-β-D-fucopyranoside(LobatosideI,3),3-O-β-D-galactopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→3)-β-D-glucuronopyranosylgypsogenin-28-O-β-D-xylopyranosyl-(1→4)-[β-D-glucopyranosyl-(1→3)]-α-L-rhamnopyranosyl(1→2)-β-D-fucopyranoside(4),3-O-β-D-galactopyranosyl-(1→）-β-D-glucuro-nopyranosyl-grpsogenin-28-O-β-D-xylopyranosyl-(1→4)-[β-D-6-O-acetylglucopyranosyl-(1→3)-β-D-glucuro-nopyranosyl-gypsogenin-28-O-β-D-xylopyranosyl-(1→4)-[β-D-6-O-acetylglucopyranosyl-(1→3)]-α-L-rh-amnopyranosyl(1→2)-β-D-fucopyranoside(5),其中5为新化合物,1和2为首次从自然界中分离得到。     

西南远志中皂苷类成分的分离与鉴定

采用乙醇回流提取,通过硅胶柱、HPD100大孔树脂、Sephadex LH-20、半制备HPLC分离方法,运用现代谱学方法从西南远志中分离并鉴定了4个齐墩果酸型皂苷类化合物,均为顺反异构体,所用实验方法并不能有效分开。他们分别是:(E/Z)-PolygalasaponinXLIV(1),3-O-β-D-glucopyranosyl presenegenin 28-O-β-D-galactopyr-anosyl-(1→4)-β-D-xylopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→2)-[6-O-acetyl-β-D-glucopyranosyl-(1→3)]-{4-O-([E/Z)-3,4-dimethoxycinnamoyl}]-β-D-fucopyranosyl ester(2),(E/Z)-PolygalasaponinXXX(3)(,E/Z)-senegasaponin C(4),均为首次从该种植物中分离得到。     

Xanthones from Tovomita Excelsa

The trunk wood of Tovomita excelsa (Guttiferae) from north-eastern Brazil contains, besides betulinic acid, 1,5-dihydroxy-6-methoxyxanthone, 1,6-dihydroxy-5-methoxyxanthone, 5,6-dihydroxy-1-methoxyxanthone and 1,7- dihydroxy-6-methoxyxanthone.     

黄花远志的新齐墩果烷型三萜皂甙

从云南产远志科药用植物黄花远志(PolygalaarillataBuchHamexDDon)茎皮的乙醇提取物中分离得到4个新的齐墩果烷型三萜皂甙,命名为黄花远志皂甙(arillatanoside)A～D。同时还分离得到1个已知的三萜皂甙远志甙(polygalasaponin)XXXV。它们的结构通过波谱方法推定。     

Isolation and Identification of Steroidal Saponins from Dioscorea panthaica Prain et Burkill

Two steroidal saponins have been isolated from the rhizomes of Dioscorea panthaica Prain et Burkill. collected from Sichuan province. They were identified as 3-0-{α-L- rhamnopyranosyl (1→4)- [α-L-rhamnopyranosyl (1→2) ]-β-D-glucopyranosyl } -diosgenin (dioscin) and 3-O-{β-D-glucopyranosyl (1→3)-[α-L-rhamnopyranosyl (1→2)]-β-D-glucopyranosyl}-diosgenin (gracillin) on the basis of mp., m. mp., TLC. acetylation, acid hydrolysis, IR, MS, and 13C NMR.     

Chemical constituents of Polygala tenuifolia roots and their inhibitory activity on lipopolysaccharide-induced nitric oxide production in BV2 microglia

A methanolic extract of the roots of Polygala tenuifolia (Polygalaceae) significantly attenuated nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated BV2 microglia cells. Five xanthones, 1-hydroxy-7-methoxyxanthone (1), 3,6-dihydroxy-1,2,7-trimethoxyxanthone (2), 1,3,6-trihydroxy-2,7-dimethoxyxanthone (3), 1,7-dihydroxy-2,3-dimethoxyxanthone (4) and 1,7-dihydroxy-3-methoxyxanthone (5), and five phenylpropanoids, 4-hydroxy-3-methoxypropiophenone (6), methyl 4-hydroxy-3-methoxycinnamic acid (7), 3,4,5-trimethoxycinnamic acid (8), 4-methoxycinnamic acid (9) and β-d-(3-O-sinapoyl) fructofuranosyl-α-d-(6-O-sinapoyl)glucopyranoside (10), were isolated from CHCl(3) fraction using bioactivity-guided fractionation. Among these compounds, compounds 1, 2, 4, 5 and 7 showed significant inhibitory effects on LPS-induced NO production in BV2 microglia cells at the concentration ranging from 10.0 to 100.0 μM.